Hanjoon Alex Kim - 04 Apr 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
Chief Operating Officer
Signature
/s/ Hanjoon Alex Kim by Nicholas Khadder, Attorney-in-Fact
Issuer symbol
LAB
Transactions as of
04 Apr 2022
Net transactions value
$0
Form type
4
Filing time
06 Apr 2022, 18:35:42 UTC
Next filing
06 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Restricted Stock Units Award $0 +280,732 $0.000000 280,732 04 Apr 2022 Common Stock 280,732 Direct F1, F2
transaction LAB Stock Option (Right to Buy) Award $0 +1,617,775 $0.000000 1,617,775 04 Apr 2022 Common Stock 1,617,775 $3.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.
F2 Restricted Stock Units vest in four equal annual installments beginning April 4, 2023.
F3 The Option becomes exercisable as to 1/4th of the underlying shares on April 4, 2023, and as to an additional 1/48th of the total number of shares each month thereafter.